Biotech Graveyard
Welcome to the Fierce Biotech Graveyard, our annual ritual remembering the biotechs we lost in 2025 and those on the brink. In this episode, Fierce Biotech’s Darren Incorvaia and Gabrielle…
Amid the dip, biotech execs share silver linings in a tumultuous environment
Ten months into 2025, and it’s clear the year hasn’t unfolded as many had expected—or hoped. Marked by a persistent bear market and compounded by geopolitical tensions and regulatory uncertainty,…